BSECompany Update3d ago · 17 Aug 2026, 03:36 pm

Announcement under Regulation 30 (LODR)- Newspaper Publication for the Unaudited Standalone and Consolidated Financial Results for the Qtr ended 30.06.2026

Medicamen Biotech Ltd-$ · 531146

✦ AI SummaryResults

Medicamen Biotech Ltd has announced the publication of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

f6a8ac24-8eb5-473b-a1b5-71edf196c960.pdf

pdf

Download →
View document text
Ref: STEX/Results/Published-2026-27 Date: 17.08.2026 BSE Limited National Stock Exchange of India Ltd Floor 25, P J Towers Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai – 400 051 BSE Code-531146 NSE Code: MEDICAMEQ Sub. : Copy of Publication for Un-audited Financial Results for the quarter ended on June 30, 2026 Dear Sir, Pursuant to regulation 30 & 47 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015 (“the Regulations”), please find enclosed newspaper cutting with regard to the publication of extract of Un-audited Financial Results of the Company for the quarter ended on June 30, 2026 approved by the Board of Directors at their Meeting held on 14.08.2026. The copy of the results published in the Financial Express and Jansatta dated 15.08.2026 is enclosed. This is for your information and records. Kindly acknowledge the receipt. Thanking You, Yours truly, For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS-44157 Encl: As above.